共 113 条
[1]
Sibai B(2005)Preeclampsia Lancet 365 785-799
[2]
Dekker G(2005)Latest advances in understanding preeclampsia Science 308 1592-1594
[3]
Kupferminc M(2003)Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 649-658
[4]
Redman CW(2003)Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria J Biol Chem 278 12605-12608
[5]
Sargent IL(2010)Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia Prenat Diagn 30 191-197
[6]
Maynard SE(2008)First trimester serum levels of soluble endoglin and soluble fms like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia Am J Obstet Gynecol 199 266.e1-266.e6
[7]
Min JY(2008)The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for gestational age J Matern Fetal Neonatal Med 21 279-287
[8]
Merchan J(2007)Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia Am J Obstet Gynecol 196 239.e1-239.e6
[9]
Lim KH(2004)Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 672-683
[10]
Li J(2007)Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 137-142